| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |